Westlake Chemical (NYSE: WLK) reported Q2 EPS of ($1.11), $1.20 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $2.95 billion versus the consensus estimate of $3.01 billion.

For earnings history and earnings-related data on Westlake Chemical (WLK) click here.